Kernel Flow

Kernel Flow

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Kernel, founded in 2016 by Bryan Johnson, is a private neurotech company based in Los Angeles pioneering accessible, high-resolution brain measurement. Its core product, Kernel Flow, is a wearable, time-domain fNIRS system engineered to provide lab-grade data with the portability needed for real-world clinical and research applications. The company is building a commercial business through direct-to-consumer wellness scans at partner clinics while simultaneously advancing a pipeline of potential medical markers for conditions like depression and cognitive impairment. With over $50M invested and a growing database of scans, Kernel is positioning itself at the intersection of digital health, neuroscience, and AI.

NeurosciencePsychiatry

Technology Platform

Kernel Flow: A wearable, time-domain functional near-infrared spectroscopy (TD-fNIRS) system with 3,500 measurement channels for whole-head coverage. It combines the portability of wearables with lab-grade precision, using time-domain photon tracking for high spatial resolution and absolute measurements. The platform includes motion tolerance, quick setup, automated quality control, and cloud connectivity for longitudinal data analysis.

Opportunities

Kernel has a dual opportunity to capture the growing consumer wellness market for brain tracking while developing clinically validated biomarkers for major neurological and psychiatric conditions.
Its scalable platform could become a standard tool for clinical trials, enabling better patient stratification and treatment effect measurement, and eventually integrate into routine clinical care for personalized medicine.

Risk Factors

Key risks include the failure to clinically validate its biomarkers in large-scale studies, slow adoption and reimbursement challenges in the medical market, and intense competition from other neuroimaging and digital assessment technologies that could erode its technical advantage.

Competitive Landscape

Kernel competes in the broad neurotechnology space. In wellness, it faces competition from consumer EEG headsets (e.g., Muse) and digital cognitive assessment apps. In the clinical/research domain, competitors include other fNIRS companies (e.g., NIRx, Artinis), established modalities like fMRI and EEG, and a growing number of startups developing novel brain sensing technologies. Kernel's differentiation lies in its claimed superior data quality (time-domain fNIRS) at a scalable, wearable form factor.